Top Markets
#1 TENDIES TENDIES +24.04%
#2 Helium Helium +19.91%
#3 Pons Pons +18.94%
#4 Songbird Songbird +15.59%
#5 Biconomy Biconomy +12.62%
#6 MarsCoin MarsCoin +11.00%
#7 OSK OSK +9.81%
#8 pipedog pipedog +9.35%
#9 Lista DAO Lista DAO +8.67%
#10 Clearpool Clearpool +7.13%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
HPGC Renmintongtai Pharmaceutical Corporation HPGC Renmintongtai Pharmaceutical Corporation

HPGC Renmintongtai Pharmaceutical Corporation

600829
Rank in Stocks #10252
HPGC Renmintongtai Pharmaceutical Corporation is a pharmaceutical enterprise... HPGC Renmintongtai Pharmaceutical Corporation is a pharmaceutical enterprise actively involved in the wholesale and retail distribution of diverse medicinal products across China and internationally. Its extensive product portfolio encompasses traditional Chinese medicines, herbal remedies, chemical preparations, antibiotics, biologics, biochemical drugs, medical equipment, and health-related items. The company also extends its operations to include logistics services, specifically warehousing and distribution. Additionally, it offers comprehensive hospital services covering medical treatment, scientific research, disease prevention, health promotion, rehabilitation, blood purification, and renal disease management. Through its e-commerce platform, HPGC Renmintongtai markets a broad selection of items, including Chinese and Western pharmaceuticals, traditional Chinese herbs, nutritional supplements, medical devices, cosmetics, and everyday necessities. The company maintains a significant retail presence with 319 chain stores located throughout Heilongjiang Province. Established in 1950 and headquartered in Harbin, China, HPGC Renmintongtai Pharmaceutical Corporation operates as a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
Share Price
$1.49
Last synced: 2026-08-28
Market Cap
$866.39M
Change (1 day)
-2.55%
Change (1 year)
30.24%
Country
CN
Trade HPGC Renmintongtai Pharmaceutical Corporation (600829)

Category

Healthcare
Revenue for HPGC Renmintongtai Pharmaceutical Corporation (600829)
Revenue in Aug 2026 TTM: 0
According to HPGC Renmintongtai Pharmaceutical Corporation latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for HPGC Renmintongtai Pharmaceutical Corporation from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN